G
Galapagos NV
GLPG
26.970
USD
0.27
(1.01%)
مفتوح الان
حجم التداول
3,697
الربح لكل سهم
0
العائد الربحي
0
P/E
59
حجم السوق
2,013,814,490
الأخبار
العنوان: Galapagos NV
القطاع: Healthcare
الصناعة: Biotechnology
Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.